[go: up one dir, main page]

FI965114A7 - Pharmaceutical composition for the prevention and (or) treatment of viral infections and optionally inflammations, and method of treating them - Google Patents

Pharmaceutical composition for the prevention and (or) treatment of viral infections and optionally inflammations, and method of treating them Download PDF

Info

Publication number
FI965114A7
FI965114A7 FI965114A FI965114A FI965114A7 FI 965114 A7 FI965114 A7 FI 965114A7 FI 965114 A FI965114 A FI 965114A FI 965114 A FI965114 A FI 965114A FI 965114 A7 FI965114 A7 FI 965114A7
Authority
FI
Finland
Prior art keywords
inflammations
prevention
treating
optionally
treatment
Prior art date
Application number
FI965114A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI965114A0 (en
Inventor
Kurt Berg
Soeren Broegger Christensen
Carsten Boye-Knudsen
Chen Ming
Beth Simonsen
Original Assignee
Kurt Berg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kurt Berg filed Critical Kurt Berg
Publication of FI965114A7 publication Critical patent/FI965114A7/en
Publication of FI965114A0 publication Critical patent/FI965114A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A61K9/0058—Chewing gums
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Zoology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FI965114A 1994-06-20 1996-12-19 Pharmaceutical composition for prophylaxis and (or) treatment of viral infections and possibly inflammations and method of treating the same FI965114A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DK72294 1994-06-20
DK92694 1994-08-09
PCT/DK1995/000256 WO1995035103A1 (en) 1994-06-20 1995-06-20 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof

Publications (2)

Publication Number Publication Date
FI965114A7 true FI965114A7 (en) 1996-12-19
FI965114A0 FI965114A0 (en) 1996-12-19

Family

ID=26064526

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965114A FI965114A0 (en) 1994-06-20 1996-12-19 Pharmaceutical composition for prophylaxis and (or) treatment of viral infections and possibly inflammations and method of treating the same

Country Status (10)

Country Link
EP (1) EP0762876A1 (en)
JP (1) JPH10504279A (en)
KR (1) KR970703759A (en)
CN (1) CN1158566A (en)
AU (1) AU689603B2 (en)
CA (1) CA2193396A1 (en)
EE (1) EE9600190A (en)
FI (1) FI965114A0 (en)
NO (1) NO965468L (en)
WO (1) WO1995035103A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4995597A (en) * 1996-10-23 1998-05-15 Vertex Pharmaceuticals Incorporated Methods of using sucrose octasulfate to treat or prevent enveloped virus infection
ES2162410T3 (en) * 1997-01-09 2001-12-16 Bifodan As USE OF DICHLOROBENCILIC ALCOHOL TO MAKE A PREPARATION FOR TOPICAL INFLAMMATION TREATMENT.
WO1998032443A1 (en) * 1997-01-24 1998-07-30 Marigen S.A. Ultramicro-emulsions of spontaneously dispersible concentrates containing antitumorally, antivirally and antiparasitically active esters of pentacyclic triterpenes
US6124362A (en) * 1998-07-17 2000-09-26 The Procter & Gamble Company Method for regulating hair growth
US6482857B1 (en) 1998-07-17 2002-11-19 The University Of Texas Southwestern Medical Center Compositions which contain triterpenes for regulating hair growth
CA2434670C (en) * 2001-01-12 2010-05-11 Bsp Pharma Dihydro-triterpenes in the treatment of viral infections, cardiovascular disease, inflammation, hypersensitivity or pain
FR2822821B1 (en) * 2001-04-03 2004-05-07 Pharmascience Lab LUPINE SEED HULL EXTRACT CONTAINING LUPEOL, ESPECIALLY EXTRACT RICH IN LUPEOL AND PROCESS FOR PREPARING THE SAME
CN104761460B (en) * 2015-03-26 2017-06-20 苏州沪云肿瘤研究中心股份有限公司 Glaucocalyxin A derivative and preparation method and application thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV

Also Published As

Publication number Publication date
AU689603B2 (en) 1998-04-02
KR970703759A (en) 1997-08-09
JPH10504279A (en) 1998-04-28
CA2193396A1 (en) 1995-12-28
NO965468D0 (en) 1996-12-19
NO965468L (en) 1997-02-19
FI965114A0 (en) 1996-12-19
CN1158566A (en) 1997-09-03
AU2734095A (en) 1996-01-15
WO1995035103A1 (en) 1995-12-28
EP0762876A1 (en) 1997-03-19
EE9600190A (en) 1997-06-16

Similar Documents

Publication Publication Date Title
TJ270B (en) 5,6-Dichlorobenzimidazole derivatives process for their preparation pharmaceutical composition and method of treatment or prophylaxis of virus infections
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1128832A4 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
NO991700D0 (en) Benzimidazole-2-carbamates for the treatment of viral infections and cancer
BR9407799A (en) Composition of matter treatment method and pharmaceutical composition
DE69524365D1 (en) Process for the isolation and purification of 2'-deoxy-2 ', 2'-difluoronucleosides
FI971969A0 (en) Compositions and method of use for the treatment of hemorrhoids
ID27457A (en) COMPOSITION FOR HIV TREATMENT AND OTHER VIRUS INFECTIONS
EP0939835A4 (en) Compositions and methods for treating viral infections
EP1001782A4 (en) 5,6-HETEROARYL-DIPYRIDO (2-3-b: 3 ', 2'-f) AZEPINS AND THE USE THEREOF FOR PROPHYLAXIS AND TREATMENT OF HIV INFECTIONS
AU3636695A (en) Method, compositions, and apparatus for treating and preventing respiratory viral infections
EE9800234A (en) Method of treatment and pharmaceutical composition
HUP9900680A3 (en) Acyclic nucleoside derivatives, process for producing them, pharmaceutical compositions containing them and method for the treatment of viral infections
GB9709360D0 (en) Methods for the treatment of herpes virus infections
EP0577243A3 (en) HIV neutralizing recombinant antibodies for the treatment and prevention of HIV infections.
FI965114A7 (en) Pharmaceutical composition for the prevention and (or) treatment of viral infections and optionally inflammations, and method of treating them
GB9304746D0 (en) Treatment of viral infections
EE9800164A (en) Pharmaceutical composition and method for treating epithelioma
FI961380A7 (en) Compositions for the prevention and treatment of tumors caused by viruses
IL116925A (en) Combinations of compounds useful for treating HIV infections and pharmaceutical compositions comprising these combinations
BR9710544A (en) Composite treatment method and pharmaceutical composition
LV12172A (en) Composition for organ cryoconservation um treatment of viral and bacterial infections
FI951655L (en) Treatment of H. pylori infections
FI944687L (en) Composition for the prevention and treatment of myopia